Announced Mon, 8 Jun · 15:59 IST
Eris Lifesciences Limited has informed the Exchange regarding 'payment made of theinterest to the holders of Non-convertible Debentures'.
Credit & Debt View source PDF
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹1371.70
prior close
₹1370.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.1-0.2-0.3-0.5-0.4+2.1+0.7+0.3+4.0+5.7+4.3——
Up moveDown movePending
AI summary
Eris Lifesciences has informed the stock exchange that it has made an interest payment to the holders of its Non-convertible Debentures (NCDs). The announcement confirms that the company has met its scheduled interest obligation on time. No specific amount has been disclosed in the headline. This is a routine debt servicing update confirming timely compliance with NCD terms.
Likely market impact
This is a routine compliance update and signals that Eris Lifesciences is servicing its debt obligations on time, which is mildly positive for bondholders. No material impact expected on the stock price from this disclosure alone.